Chengdu Minshan Institute of Biomaterials (hereinafter referred to as "the Institute") is led by Prof. Xingdong Zhang (Academician of the Chinese Academy of Engineering) and Prof. Yunbing Wang (Dean, School of Biomedical Engineering). It is a newly established research and development institution in Chengdu High-tech Zone, designed to break through critical core technologies, explore new paths for scientific and technological transfer, and implement the “Minshan Action” plan’s third batch of “Leading the List” projects.

The Institute leverages the resource advantages of China’s first national-level biomaterials R&D institution—National Engineering Research Center for Biomaterials (referred to as "National Biomaterials Center"). Building on its foundational knowledge in biomaterials and technologies, the Institute focuses on cutting-edge core domains to advance R&D in biomedical field .

Targeting critical medical device demands including: Recombinant humanized collagen; Implantable biodegradable materials; Cardiovascular implants; Liquid biopsy products based on nanomaterials & spectral platforms; Surface functionalization of medical devices; Liquid biopsy for tumors and other conditions; Personalized acellular matrix for tissue repair. The Institute conducts joint research and development through industry-academia-medical collaborations on key core technologies, effectively promoting medical-engineering integration and technology commercialization, establishing a comprehensive innovation system from diagnosis to treatment, and developing products urgently needed in clinical practice.

We Strive to achieve objectives within 5 years: 20+ industry-leading experts recruited; 110-member R&D team established; 60 independent IP portfolios secured; 30 innovations commercialized; 5 startups incubated and >¥1B total valuation attained. We will finally build a domestically leading, globally first-class biomaterials innovation hub, creating: Full innovation-industrial chain for biomaterials & medical devices; Talent highland & industrial cluster; Global epicenter for pioneering biomaterials R&D and applications; Model zone for technology transfer and industrialization.